PMC:7212965 / 64199-64458
Annnotations
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T458","span":{"begin":167,"end":169},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"}],"text":"4.7% (10/214), not included in the analysisPresent on admissionSevere disease 6.8% (6/88), nonsevere disease 3.2% (4/126)Nausea and vomiting: NR AST 26 (8–8191)Severe 34 (8–8191), non-severe 23 (9–244)ALT 26 (5–1933)Severe 32.5 (5–1933), non-severe 23 (6–261)"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T48437","span":{"begin":142,"end":144},"obj":"Chemical"},{"id":"T42473","span":{"begin":145,"end":148},"obj":"Chemical"}],"attributes":[{"id":"A90890","pred":"chebi_id","subj":"T48437","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"},{"id":"A31097","pred":"chebi_id","subj":"T42473","obj":"http://purl.obolibrary.org/obo/CHEBI_76649"}],"text":"4.7% (10/214), not included in the analysisPresent on admissionSevere disease 6.8% (6/88), nonsevere disease 3.2% (4/126)Nausea and vomiting: NR AST 26 (8–8191)Severe 34 (8–8191), non-severe 23 (9–244)ALT 26 (5–1933)Severe 32.5 (5–1933), non-severe 23 (6–261)"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T291","span":{"begin":121,"end":140},"obj":"Phenotype"}],"attributes":[{"id":"A291","pred":"hp_id","subj":"T291","obj":"http://purl.obolibrary.org/obo/HP_0002017"}],"text":"4.7% (10/214), not included in the analysisPresent on admissionSevere disease 6.8% (6/88), nonsevere disease 3.2% (4/126)Nausea and vomiting: NR AST 26 (8–8191)Severe 34 (8–8191), non-severe 23 (9–244)ALT 26 (5–1933)Severe 32.5 (5–1933), non-severe 23 (6–261)"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T496","span":{"begin":0,"end":259},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"4.7% (10/214), not included in the analysisPresent on admissionSevere disease 6.8% (6/88), nonsevere disease 3.2% (4/126)Nausea and vomiting: NR AST 26 (8–8191)Severe 34 (8–8191), non-severe 23 (9–244)ALT 26 (5–1933)Severe 32.5 (5–1933), non-severe 23 (6–261)"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"2379","span":{"begin":121,"end":127},"obj":"Disease"},{"id":"2380","span":{"begin":132,"end":140},"obj":"Disease"}],"attributes":[{"id":"A2379","pred":"tao:has_database_id","subj":"2379","obj":"MESH:D009325"},{"id":"A2380","pred":"tao:has_database_id","subj":"2380","obj":"MESH:D014839"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"4.7% (10/214), not included in the analysisPresent on admissionSevere disease 6.8% (6/88), nonsevere disease 3.2% (4/126)Nausea and vomiting: NR AST 26 (8–8191)Severe 34 (8–8191), non-severe 23 (9–244)ALT 26 (5–1933)Severe 32.5 (5–1933), non-severe 23 (6–261)"}